Adrenal insufficiency and exogenous Cushing's syndrome in a patient receiving inhaled fluticasone and ritonavir

Endocrinol Diabetes Nutr. 2017 Jun-Jul;64(6):338-339. doi: 10.1016/j.endinu.2017.02.006. Epub 2017 Mar 24.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / therapeutic use
  • Adrenal Insufficiency / chemically induced*
  • Adrenal Insufficiency / drug therapy
  • Anti-Asthmatic Agents / adverse effects*
  • Anti-Asthmatic Agents / pharmacokinetics
  • Anti-Asthmatic Agents / therapeutic use
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Asthma / complications
  • Asthma / drug therapy
  • Comorbidity
  • Cushing Syndrome / chemically induced*
  • Cushing Syndrome / drug therapy
  • Cytochrome P-450 CYP3A Inhibitors / adverse effects*
  • Cytochrome P-450 CYP3A Inhibitors / pharmacokinetics
  • Cytochrome P-450 CYP3A Inhibitors / therapeutic use
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Fluticasone / adverse effects*
  • Fluticasone / pharmacokinetics
  • Fluticasone / therapeutic use
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / pharmacokinetics
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Hydrocortisone / therapeutic use
  • Middle Aged
  • Ritonavir / adverse effects*
  • Ritonavir / pharmacokinetics
  • Ritonavir / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anti-Asthmatic Agents
  • Anti-HIV Agents
  • Cytochrome P-450 CYP3A Inhibitors
  • HIV Protease Inhibitors
  • Fluticasone
  • Ritonavir
  • Hydrocortisone